I believe it's $15 million for 51% of company, plus guaranteed revenue of
$15 million over the period including 2020 and continuing until twelve months after the Company has completed development of a functioning product integrating the QMC HealthID IP and Innova Medical Group’s products.
Looks like the $15 million financing has 154,228,625 shares being issued.
So looks like the other $15 million will be for about 600 million shares.
So now comes the vote for selling the company and diluting the company by 50%!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.